We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$94.3B
AUM Growth
+$7.96B
(+9.2%)
Cap. Flow
-$2.37B
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
2,315
New
140
Increased
934
Reduced
1,002
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$335M |
| 2 |
Exelon
EXC
|
+$314M |
| 3 |
Procter & Gamble
PG
|
+$241M |
| 4 |
TripAdvisor
TRIP
|
+$208M |
| 5 |
Starbucks
SBUX
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$551M |
| 2 |
Target
TGT
|
+$514M |
| 3 |
CELG
Celgene Corp
CELG
|
+$495M |
| 4 |
Cigna
CI
|
+$369M |
| 5 |
Costco
COST
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.77% |
| 2 | Healthcare | 19.09% |
| 3 | Consumer Discretionary | 13.69% |
| 4 | Industrials | 9.28% |
| 5 | Financials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANAT
1076
DELISTED
American National Group, Inc. Common Stock
ANAT
| $3.84M | ﹤0.01% |
31,757
+3,538
| +13% | +$486K |
|
1077
Adtran
ADTN
$622M
| $3.83M | ﹤0.01% |
+279,902
| New | +$3.87M |
|
|
CRON
1078
Cronos Group
CRON
$1.11B
| $3.83M | ﹤0.01% |
+208,516
| New | +$3.91M |
|
|
CEO
1079
DELISTED
CNOOC Limited
CEO
| $3.83M | ﹤0.01% |
20,591
| – | – |
|
|
ARI
1080
Apollo Commercial Real Estate
ARI
$871M
| $3.82M | ﹤0.01% |
210,071
| – | – |
|
1081
Generac Holdings
GNRC
$12.2B
| $3.79M | ﹤0.01% |
74,076
-44,451
| -38% | -$2.32M |
|
|
HPP
1082
Hudson Pacific Properties
HPP
$740M
| $3.78M | ﹤0.01% |
15,671
+11,180
| +249% | +$2.54M |
|
|
HSII
1083
DELISTED
Heidrick & Struggles
HSII
| $3.77M | ﹤0.01% |
98,238
+15,936
| +19% | +$575K |
|
|
ONCE
1084
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $3.74M | ﹤0.01% |
+32,848
| New | +$2.41M |
|
1085
Newmark Group
NMRK
$2.52B
| $3.73M | ﹤0.01% |
447,430
-665,238
| -60% | -$6.31M |
|
1086
Toro Company
TTC
$9.4B
| $3.73M | ﹤0.01% |
54,330
-16,782
| -24% | -$1.06M |
|
1087
Nutanix
NTNX
$17.4B
| $3.73M | ﹤0.01% |
99,001
-117,817
| -54% | -$5.39M |
|
|
ACOR
1088
DELISTED
Acorda Therapeutics
ACOR
| $3.73M | ﹤0.01% |
2,337
+951
| +69% | +$1.71M |
|
|
TBCH
1089
Turtle Beach Corp
TBCH
$251M
| $3.73M | ﹤0.01% |
327,920
-239,012
| -42% | -$3.6M |
|
1090
Weis Markets
WMK
$1.78B
| $3.72M | ﹤0.01% |
91,101
-9,720
| -10% | -$457K |
|
1091
Xylem
XYL
$28.3B
| $3.71M | ﹤0.01% |
46,912
-39,090
| -45% | -$2.85M |
|
1092
Oxford Industries
OXM
$556M
| $3.7M | ﹤0.01% |
49,200
-23,454
| -32% | -$1.8M |
|
1093
W&T Offshore
WTI
$577M
| $3.69M | ﹤0.01% |
535,437
+121,057
| +29% | +$658K |
|
1094
Masco
MAS
$14.7B
| $3.69M | ﹤0.01% |
93,905
-535,778
| -85% | -$19.1M |
|
1095
Caleres
CAL
$486M
| $3.69M | ﹤0.01% |
149,468
-76,971
| -34% | -$2.2M |
|
|
TYPE
1096
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $3.68M | ﹤0.01% |
185,087
-4,879
| -3% | -$87.9K |
|
|
AHT
1097
Ashford Hospitality Trust
AHT
$20.7M
| $3.68M | ﹤0.01% |
783
+457
| +140% | +$2.2M |
|
1098
UDR
UDR
$12.1B
| $3.65M | ﹤0.01% |
80,283
+30,610
| +62% | +$1.33M |
|
1099
Worthington Enterprises
WOR
$2.79B
| $3.64M | ﹤0.01% |
158,048
-67,262
| -30% | -$1.54M |
|
|
ICPT
1100
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.64M | ﹤0.01% |
32,507
+211
| +0.7% | +$23.1K |
|
Similar funds
VGA
AQR Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, AQR Capital Management held 2,315 positions worth $94.3B, up 9.2% from $86.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q1 2019 filing shows 140 new, 934 increased, 1,002 reduced and 155 closed positions. Its largest new stake was Canopy Growth: 121,700 shares worth $52.7M. The largest sale was Walmart Inc, an estimated $551M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AQR Capital Management's largest Q1 2019 buy was Canopy Growth: 121,700 shares worth $52.7M.
- AQR Capital Management added most to Biogen in Q1 2019, an estimated $335M increase.
- AQR Capital Management's biggest Q1 2019 reduction was Walmart Inc, cutting an estimated $551M.
- AQR Capital Management fully exited Dun & Bradstreet in Q1 2019, selling an estimated $74.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $94.3B portfolio in Q1 2019.
- AQR Capital Management opened 140 new positions and closed 155 in Q1 2019.
- AQR Capital Management's portfolio value rose 9.2% quarter-over-quarter to $94.3B.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.